Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HMGCR | P04035 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8398377 | 0.80 | ALDH1A1 (0.42) | DGAT1ALDH1A1TSHRTET2 | |
| SCHEMBL2712242 | 0.80 | DGAT1 (0.39) | DGAT1ALDH1A1USP2SMN1; SMN2 | |
| SCHEMBL2219915 | 0.79 | DGAT1 (0.34) | DGAT1TET2 | |
| SCHEMBL78520 | 0.78 | DGAT1 (0.46) | DGAT1CHRM1CHRM2CHRM3ALDH1A1 | |
| SCHEMBL3896600 | 0.78 | DGAT1 (0.37) | DGAT1ALDH1A1USP2SMN1; SMN2 | |
| SCHEMBL33412 | 0.78 | ALDH1A1 (0.50) | DGAT1ALDH1A1TSHRGAAUSP2 | |
| SCHEMBL28298942 | 0.78 | ALDH1A1 (0.50) | DGAT1ALDH1A1TSHRGAAUSP2 | |
| Methacrylic Acid SCHEMBL4637357 | 0.77 | ALDH1A1 (0.44) | DGAT1ALDH1A1TSHRTET2 | |
| SCHEMBL8395216 | 0.77 | ALDH1A1 (0.33) | ALDH1A1 | |
| Methacrylic Acid SCHEMBL6011830 | 0.77 | ALDH1A1 (0.44) | DGAT1ALDH1A1TSHRTET2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240030550-A1 | COPOLYMER FOR SEPARATOR, AND SECONDARY BATTERY COMPRISING SAME | HANSOL CHEMICAL CO., LTD (KR) | 2024-01-25 | — | — | US | disclosed |
| EP-4242241-A1 | COPOLYMER FOR SEPARATOR, AND SECONDARY BATTERY COMPRISING SAME | Hansol Chemical Co., Ltd (KR) | 2023-09-13 | — | — | EP | disclosed |
| WO-2023074967-A1 | COPOLYMER FOR SEPARATOR, AND SECONDARY BATTERY COMPRISING SAME | 주식회사 한솔케미칼 | 2023-05-04 | — | — | WO | disclosed |
| CN-107033186-A | Posaconazole derivative, its pharmaceutical composition and purposes | 武汉朗来科技发展有限公司 | 2017-08-11 | — | — | CN | disclosed |
| CN-103597043-B | Bottom antireflective coating compositions and its method | 默克专利有限公司 | 2017-04-05 | — | — | CN | disclosed |
| US-9045486-B2 | Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease | SAVIRA PHARMACEUTICALS GMBH (AT) | 2015-06-02 | — | — | US | disclosed |
| US-20140194431-A1 | PYRIMIDONE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE | SAVIRA PHARMACEUTICALS GMBH (AT) | 2014-07-10 | — | — | US | disclosed |
| CN-103597043-A | Bottom antireflective coating compositions and processes thereof | AZ ELECTRONIC MATERIALS USA | 2014-02-19 | — | — | CN | disclosed |
| CN-101305321-A | Developable undercoating composition for thick photoresist layers | AZ ELECTRONIC MATERIALS USA (US) | 2008-11-12 | — | — | CN | disclosed |
| US-5973094-A | Functional polymers | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1999-10-26 | — | — | US | disclosed |
| EP-0595286-B1 | Organic solvent dispersible polyamide modified resins for use in coating compositions | BASF CORP (US) | 1999-05-06 | — | — | EP | disclosed |
| EP-0794199-A2 | Novel functional polymers | WAKO PURE CHEMICAL INDUSTRIES, LTD (JP) | 1997-09-10 | — | — | EP | disclosed |
| EP-0595286-A1 | Organic solvent dispersible polyamide modified resins for use in coating compositions | BASF CORPORATION (US) | 1994-05-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140194431-A1 | PYRIMIDONE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE | TPMT, XDH, DPYD | DGAT1 3963/4885CHRM1 2915/4885CHRM2 3889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.